Skip to main content
. 2018 Dec 14;191(1):61–69. doi: 10.1007/s12011-018-1604-7

Table 1.

Baseline characteristics of subjects

CON (n = 50) IFG (n = 12) P IGT (n = 15) P T1D (n = 25) P T2D (n = 137) P
Cu (mg/L) 0.8 (0.7–0.99) 1.13 (1.02–1.29) 0.001* 1.15 (1.03–1.24) < 0.001* 0.94 (0.75–1.19) 0.352 1.07 (0.95–1.33) < 0.001*
UCu (μg/L) 25 (22–40) 32 (28.3–42.5) 0.293 26 (24–28) 0.306 25 (23–27.5) 0.187 30 (25.5–40.5) 0.408
Zn (mg/L) 0.81 (0.67–0.93) 0.75 (0.7–0.84) 0.462 0.77 (0.67–0.87) 0.834 0.59 (0.53–0.75) 0.056 0.61 (0.51–0.75) < 0.001*
UZn (mg/L) 0.2 (0.14–0.32) 0.32 (0.26–0.37) 0.745 0.27 (0.19–0.41) 0.836 0.86 (0.67–0.91) < 0.001* 0.48 (0.38–0.57) < 0.001*
Zn/Cu 0.92 (0.84–1.07) 0.68 (0.62–0.73) 0.009* 0.65 (0.62–0.77) 0.002* 0.64 (0.57–0.77) 0.018* 0.56 (0.43–0.68) <0.001*
Mg (mg/L) 35.7 (30.8–39.7) 21.6 (17.4–25.7) < 0.001* 21.4 (20.5–26.8) < 0.001* 15.4 (12.2–17.7) < 0.001* 21.6 (16.4–27) < 0.001*
UMg (mg/L) 34.4 (15.1–47.3) 22.9 (14–71) 0.446 20.1 (10.7–42.1) 0.231 57.8 (46.4–65.7) 0.86 50.2 (40.1–77) 0.159
Ca (mg/L) 165 (145.8–177.2) 47.4 (25.9–52.9) < 0.001* 130.4 (111.2–133.3) < 0.001* 97.3 (77.7–111) 0.007* 95 (62.9–131) < 0.001*
UCa (mg/L) 63.3 (31–94.1) 123.6 (64.1–147.1) 0.027* 39.1 (16.1–75.1) 0.133 104.5 (44.4–169.7) 0.208 85.9 (39.1–137.8) 0.099
Se (mg/L) 0.067(0.056–0.084) 0.071(0.064–0.103) 0.021* 0.071(0.059–0.082) 0.791 0.058(0.058–0.07) 0.008* 0.063(0.045–0.086) 0.112
Use (mg/L) 0.017(0.012–0.023) 0.017(0.014–0.024) 0.544 0.009(0.006–0.017) 0.006* 0.018(0.014–0.025) 0.319 0.011(0.008–0.019) 0.007*

Data are presented as number (%) or median (interquartile range). Cu serum copper, UCu urinary copper, Zn serum zinc, UZn urinary zinc, Mg serum magnesium, Umg urinary magnesium, Ca serum calcium, UCa urinary calcium, Se serum selenium, USe urinary selenium